Events

Loading Events

« All Events

  • This event has passed.

Using Spheroid Models to Develop Relevant High-throughput Assays with Quantitative Endpoints

November 3, 2016 | 10:00 am CDT - 11:00 am CDT

Event Navigation

Significant advances in automated microscopy, imaging, and biological models are delivering more predictive, physiologically-relevant measurements for drug discovery and environmental toxicity applications. Yet, implementation challenges have been a deterrent for utilizing 3D spheroid models.

This webinar will explore the use and analysis of cancer spheroid models, as well as iPSC-derived hepatocyte and cardiomyocyte spheroids for toxicity assessment and demonstrate that historical barriers have been overcome.

Join us to learn about:

  • Selecting products and solutions for implementation of 3D spheroid models
  • Testing efficacy of anticancer drugs using cancer spheroids
  • Analyzing phenotypic characterization of compound treatments on iPSC-derived hepatocyte spheroids
  • Assessing drug effects on cardiomyocyte physiology using human iPSC-derived cardiac spheroids

Details

Date:
November 3, 2016
Time:
10:00 am CDT - 11:00 am CDT

Organizer

Molecular Devices